As an innovation-driven organization, and an early adopter of new therapeutic and diagnostic technologies, Clalit is uniquely poised to perform real-world follow-up and passive evaluation of interventions, as well as pharmaco-epidemiologic assessments.
We employ multiple methods that control for population biases, to measure real-world effectiveness of medications, vaccines, or health care interventions. This effectiveness is placed in the context of the previously-demonstrated efficacy to understand the results of the treatment or intervention within a large population.